Man receiving IV infusion Emerging research suggests that cancer therapies such as checkpoint inhibitors could be advanced by targeting a new protein.
William A. Haseltine is a writer and contributor to various publications, including Forbes and Psychology Today. With a focus on medical and scientific topics, his articles delve into subjects such as cardiovascular disease, prosthetics, myopia, gene modulation, and advancements in medical treatments. His work aims to inform readers about the latest research and developments in the field of medicine.